Delivery Order SPE2DB24D2205-SPE2DB25FEHTG
Award Date 9/18/25
Potential Completion Date 10/9/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with firm fixed pricing. This is a non-set-aside delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is executing this...
- The Defense Logistics Agency awarded a $14,651.28 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gamunex-C 10 gram/100 mL vials (100 mL quantity). This is a firm fixed-price, non-set-aside contract with a completion date of October 8, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Gamunex-C 1 gram/10 milliliter vials with a ceiling value of $1,223.80 and a completion date of September 3, 2025. This non-set-aside, firm fixed-price delivery order represents a competitively awarded contract under the company's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Gamunex-C 40 gram/400 milliliter vials with a ceiling value of $6,981.60 and an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The product will be delivered to...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for supply of Gamunex-C (immune globulin intravenous human), a specialized immunological pharmaceutical product. The firm fixed price delivery order carries a ceiling value of $11,801.40 and is scheduled for completion by September 4, 2025. This is a non-set-aside award, indicating the contract was competitively awarded. The award is performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,981.60 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400 milliliter immunoglobulin vial. The contract, issued on August 6, 2025, carries a firm fixed price and is scheduled for completion by August 27, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $28,323.36 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 20 gram/200 mL vials on July 22, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, represents a competitive award with no set-aside designation. The contractor will perform from its corporate headquarters location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $35,403.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gamunex-C 20 gram/200 milliliter vials. The contract is scheduled for completion by October 8, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $9,308.80 to AmerisourceBergen Drug Corp for the supply of Gamunex-C, a 40-gram immunoglobulin product in 400 mL vials, with performance through September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's extensive pharmaceutical supply portfolio supporting federal medical procurement needs. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,926.40 to AmerisourceBergen Drug Corp for the supply of Gamunex-C, a 40 gram/400 mL immunoglobulin product, with an ultimate completion date of June 17, 2025. The award, issued May 27, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, the...